Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
Two hundred and twelve patients diagnosed as having a missed abortion or intrauterine fetal death were managed by the use of prostaglandin E2 vaginal suppositories. The method had a high efficacy rate with 98% of the patients experiencing successful evacuation of the uterine contents. The mean time to abortion was 10.9 hours with a mean dose of 60 mg (3 suppositories). Side effects were well tolerated. Transient pyrexia was present in 36% of the patients during therapy, but returned to pretreatment levels after abortion. No intrauterine infection was observed. The risks associated with active treatment can be avoided. The ease of administration permits initiation of therapy as soon as the diagnosis is confirmed.
D000019:Abortifacient Agents / Q000627:therapeutic use; D000028:Abortion, Induced; D000030:Abortion, Missed / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000209:etiology; D005260:Female; D005313:Fetal Death / Q000150:complications / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D011458:Prostaglandins E / Q000008:administration & dosage / Q000627:therapeutic use*; D013488:Suppositories; D013997:Time Factors; D014621:Vagina
D000019:Abortifacient Agents; D011458:Prostaglandins E; D013488:Suppositories